Ponatinib for treating chronic myeloid leukaemia and acute lymphoblastic leukaemia

Final scope (PDF 115 KB)

Final matrix (PDF 97 KB)

NICE's response to comments on the draft scope and provisional matrix (PDF 405 KB)

Equality Impact Assessment (Guidance development) (PDF 123 KB)

Final appraisal determination

Final appraisal determination document (PDF 436 KB)

Committee papers (PDF 3.21 MB)

Draft guidance: 1

Committee papers (PDF 12.82 MB)

Public committee slides (PDF 1.14 MB)

Draft scope (post-referral) (PDF 128 KB)